SANJAY BHENDWAL: Open Payments
NPI 1770519944 · VINELAND, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,488 in 77 payments from 14 companies in 2025. Trend: 2023 $1,755 · 2024 $1,619 · 2025 $1,488
Food & beverage: $1,488
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $394 |
| ABBVIE INC. | 21 | $386 |
| Novo Nordisk Inc | 12 | $192 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $95 |
| Lilly USA, LLC | 4 | $74 |
| PFIZER INC. | 4 | $67 |
| Otsuka America Pharmaceutical, Inc. | 3 | $59 |
| Abbott Laboratories | 3 | $58 |
| Phathom Pharmaceuticals, Inc. | 3 | $34 |
| Axsome Therapeutics, Inc. | 2 | $34 |
Products named: VRAYLAR, BREZTRI, AIRSUPRA, Ozempic, Kerendia, UBRELVY, Rybelsus, REXULTI.
Industry payments across NJ — which companies pay providers there.
